Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Molecular and Clinical Oncology|January 26, 2019
Tolerability and safety of real-world use of pomalidomide in patients with relapsed/refractory multiple myelomaEiseki Usami, Michio Kimura, Shoya Takenaka, et al.Molecular and Clinical Oncology|August 8, 2017
Usefulness of a pharmacist outpatient service for S-1 adjuvant chemotherapy in patients with gastric cancerMichio Kimura, Makiko Go, Mina Iwai, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 23, 2016
Evaluation of the role and usefulness of a pharmacist outpatient service for patients undergoing monotherapy with oral anti-cancer agentsMichio Kimura, Makiko Go, Mina Iwai, et al.Molecular and Clinical Oncology|September 3, 2016
Neutropenia as a prognostic factor and safety of second-line therapy with S-1 for advanced or recurrent pancreatic cancerMakiko Ikagawa, Michio Kimura, Mina Iwai, et al.Molecular and Clinical Oncology|January 19, 2019
Effect of the timing of discontinuation of last-line chemotherapy on patient prognosis in advanced and recurrent gastric cancerMichio Kimura, Shiori Kawachi, Makiko Go, et al.Molecular and Clinical Oncology|July 8, 2017
Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancerMachiko Kurimoto, Michio Kimura, Eiseki Usami, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 14, 2018
The incidence and timing of leukocyte overshoot after pegfilgrastim administrationEiseki Usami, Michio Kimura, Mina Iwai, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2016
[Treatment Continuation and Safety of Eribulin for the Treatment of Metastatic Breast Cancer]Shino Adachi, Eiseki Usami, Kazutomo Okada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 21, 2012
[Tolerable evaluation for chemotherapy with S-1 plus cisplatin in elderly patients with advanced and recurrent gastric cancer]Michio Kimura, Eiseki Usami, Daisuke Ito, et al.Oncology Letters|July 3, 2015
Adherence and awareness of the therapeutic intent of oral anticancer agents in an outpatient settingMichio Kimura, Keiji Nakashima, Eiseki Usami, et al.Pageof 3